Reference | Treatment | Empirical treatment group | Susceptibility testing group | ||||
---|---|---|---|---|---|---|---|
n | % eradication | n | % eradication | ||||
ITT | PP | ITT | PP | ||||
*Eradication rate was 64% using OCA and 87% using RBC-CT. | |||||||
†Second line treatment. | |||||||
O, omeprazole; A, amoxicillin; L, lanzoprazole; M, metronidazole; C, clarithromycin; T, tinidazole; RBC, ranitidine bismuth citrate. | |||||||
ITT, intention to treat; PP, per protocol. | |||||||
Lamouliatte102† | OAM 2 weeks | 57 | 63.2 | 72.1 | 113 | 74.3 | 78.3 |
Miwa124 | LAM | 39 | 92.4 | 94.7 | 38 | 81.6 | 83.3 |
Neri125 | OCA RBC-CT | 116 | 67 | 116 | 76* | ||
Romano126 | OMC | 39 | 79.5 | 77.5 | 40 | 95 | 97.4 |
Toracchio127 | OMC | 56 | 75 | 81 | 53 | 91 | 98 |